Predicting Early Viral Control under Direct-Acting Antiviral Therapy for Chronic Hepatitis C Virus Using Pretreatment Immunological Markers

Frontiers in Immunology
James A HutchinsonJens M Werner

Abstract

Recent introduction of all-oral direct-acting antiviral (DAA) treatment has revolutionized care of patients with chronic hepatitis C virus (HCV) infection. Regrettably, the high cost of DAA treatment is burdensome for healthcare systems and may be prohibitive for some patients who would otherwise benefit. Understanding how patient-related factors influence individual responses to DAA treatment may lead to more efficient prescribing. In this observational study, patients with chronic HCV infection were comprehensively monitored by flow cytometry to identify pretreatment immunological variables that predicted HCV RNA negativity within 4 weeks of commencing DAA treatment. Twenty-three patients [genotype 1a (n = 10), 1b (n = 9), and 3 (n = 4)] were treated with daclatasvir plus sofosbuvir (SOF) (n = 15), ledipasvir plus SOF (n = 4), or ritonavir-boosted paritaprevir, ombitasvir, and dasabuvir (n = 4). DAA treatment most prominently altered the distribution of CD8+ memory T cell subsets. Knowing only pretreatment frequencies of CD3+ and naive CD8+ T cells allowed correct classification of 83% of patients as "fast" (HCV RNA-negative by 4 weeks) or "slow" responders. In a prospective cohort, these parameters correctly classified 90% o...Continue Reading

Associated Clinical Trials

References

Nov 8, 2011·Annals of Internal Medicine·David B ReinCindy M Weinbaum
Mar 19, 2014·Gastroenterology·Jean-Michel Pawlotsky
Apr 15, 2014·The New England Journal of Medicine·Jay H Hoofnagle, Averell H Sherker
Jul 23, 2014·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Barbara Rehermann, Antonio Bertoletti
Apr 26, 2015·Journal of Hepatology·UNKNOWN European Association for Study of Liver
Jul 7, 2015·Transplantation·James A Hutchinson
Nov 17, 2015·ELife·Cécile AlanioMatthew L Albert
Jan 28, 2016·Transplantation·Jens M Werner, Johannes Vermehren
Mar 12, 2016·Journal of Clinical Epidemiology·Emmanuel O OgundimuGary S Collins
May 5, 2016·Cytometry. Part a : the Journal of the International Society for Analytical Cytology·Anders H KvernelandBirgit Sawitzki
Sep 20, 2016·Journal of Hepatology·Benjamin Maasoumy, Johannes Vermehren

❮ Previous
Next ❯

Methods Mentioned

BETA
flow cytometry
PCA

Clinical Trials Mentioned

NCT02904603

Software Mentioned

SPSS
Kaluza
GraphPad Prism

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Related Papers

Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
Anna MaruyamaTrana Hussaini
The Lancet. Gastroenterology & Hepatology
Seng Gee LimCihan Yurdaydin
© 2022 Meta ULC. All rights reserved